Neonatal Outcome After Expectant Management of Preterm Premature Rupture of Membranes (PPROM) Between 34+0 and 36+6 Weeks of Gestation: A Single-Center Cohort Study

妊娠34+0至36+6周早产胎膜早破(PPROM)期待疗法后新生儿结局:一项单中心队列研究

阅读:2

Abstract

OBJECTIVES: The aim of the study was to assess adverse neonatal outcome after preterm premature rupture of membranes (PPROM) between 34+0 and 36+6 weeks of gestation in patients undergoing expectant management after PPROM according to the intrauterine inflammation, infection, or both (TRIPLE-I) criteria. STUDY DESIGN: This retrospective analysis included 323 singleton pregnancies with PPROM between 34+0 and 36+6 weeks of gestation. Groups of cases that met at least some of the TRIPLE-I diagnostic criteria and were suspected of having TRIPLE-I were created and compared with groups of cases that did not meet these criteria. RESULTS: Mean gestational age at time of birth was 35.9 weeks [IQR; 35.0-36.4], mean gestational age at time of PPROM was 34.7 [IQR; 34.0 -35.4], and mean birth weight was 2,660 g [IQR; 2,140-2,985]. Two hundred four (63.2%) infants were delivered vaginally, 107 (33.1%) via caesarean section and 12 (3.7%) women had vaginal operative delivery (vacuum extraction). There were only two cases of maternal fever, and no case met all TRIPLE-I diagnostic criteria. No significant increase in risks were found for low umbilical artery pH (OR: 1.88 (95% CI: 0.50-5.88), p = 0.29), low Apgar score (OR: 1.14 (95% CI: 0.17-4.73), p = 0.86), or need for neonatal admission to neonatal intensive care unit (NICU) due to infection (OR: 1.14 (95% CI: 0.17-4.73), p = 0.62) in women with elevated white blood cell count in performed logistic regressions. Same applied for cases with tachycardic cardiotocography (CTG). CONCLUSION: Expectant management appears to be a viable and potentially safe approach for managing cases of PPROM between 34+0 and 36+6 weeks of gestation, without significantly increasing the risk of adverse neonatal outcome. However, close monitoring, personalized care and readiness to intervene are important for optimally managing these clinical cases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。